trial · primary record
Palbociclib 125mg
Metastatic Breast Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 500 |
| Primary completion | 2028-09-01 |
| Primary endpoint | Time to Treatment Discontinuation (TTD) |
| Registry ID | NCT06377852 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:32.688Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06377852
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.